Search
Close this search box.

Olver

A life gone too soon Last week we lost a friend and a very special person. A life story that would have remained untold. He is one of the forgotten children of the world, a life made difficult by poverty, by Huntington’s disease, and by social neglect. His story, now…
A WEEK-LONG GATHERING OF FAMILIES, PATIENT ASSOCIATIONS, AT-RISK YOUTH, CLINICIANS AND SCIENTISTS IN COLOMBIA, July 4-11, 2018

A WEEK-LONG GATHERING OF FAMILIES, PATIENT ASSOCIATIONS, AT-RISK YOUTH, CLINICIANS AND SCIENTISTS IN COLOMBIA, July 4-11, 2018

Factor-H organized a series of events beginning on July 4 in Barranquilla, Colombia, with the first gathering of at-risk HD youth from 5 Latin American countries, co-organized with HDYO. The meeting was a first step in identifying and training a group of young people from South America, to extend outreach…

BRINGING MEDICAL SUPPORT TO HD CLUSTERS IN VENEZUELA

During the last couple of months, we have managed to reach a lot of patients in both San Luis and Barranquitas, the two largest communities with HD in the world. We conducted two medical assistance visits with the local HD foundations and the medical foundation Primero Auxilios. This is really…

Wave Life Sciences empieza estudios clínicos con un ASO que degrada la proteína mutante

La última vez que escribí comenté sobre la gran expectativa que tenemos todos sobre los estudios a comenzar de fase 3 con una molécula de antisense (ASO) de la compañia Ionis con Roche. Los estudios de fase 2 habían concluído positivamente, la droga era bien tolerada, y se veían claros…

Noticias sobre el estudio de Ionis/Roche con oligonucleótidos para el tratamiento de Huntington

Recientemente ha habido mucho interés en los estudios realizados por la compañia de California Ionis, en colaboración con la farmacéutica Roche de Suiza, en pacientes de Huntington. Su droga, un compuesto nuevo llamado HTT-Rx, es una molécula de ADN de la clase de fármacos llamados oligonucleótidos antisentidos, debido al hecho…

Living on the street with Huntington's

Today’s “life stories” brings us to a very difficult and sad place, but one that unfortunately exists. Many people with Huntington’s end up abandoned on the street. Whether left by their families or due to psychiatric issues that arise from the disease itself, young HD affected persons sometimes end up…
A letter from a scientist

A letter from a scientist

I am enclosing here a piece I wrote during a lengthy period in 2015, which led to the publication in Nature of a short article about the issues surrounding the Latin American HD communities. I am attaching it in its entirety here. The Nature commentary was a shortened version of…
El Papa recibe a 200 enfermos de Huntington para acabar con el estigma de esa enfermedad

El Papa recibe a 200 enfermos de Huntington para acabar con el estigma de esa enfermedad

Recordando que «Jesús salía al encuentro de los enfermos y derribaba los muros del estigma y la marginación», el Papa Francisco ha mantenido el jueves un encuentro con doscientos enfermos de Huntington, acompañados de sus familias, investigadores y benefactores hasta un total de casi dos mil personas a las que…
Dilia

Dilia

Dilia Oviedo Oviedo is 79 years old.  She had 12 children. One was stillborn. Of the 11 children that survived to adulthood, 4 already died from Huntington’s disease. 4 more are currently sick with HD, 2 in late manifest disease. Her husband died in the early 90s, and now a…
Meeting with Pope Francis at the Vatican May 18, 2017

Meeting with Pope Francis at the Vatican May 18, 2017

Factor-H is pleased to announce a private audience with Pope Francis at the Vatican on May 18, 2017 (11am) to honor Latin American families affected by HD
EN